Literature DB >> 3601241

Alterations in human linker histone-DNA binding in the presence of aluminum salts in vitro and in Alzheimer's disease.

W J Lukiw, T P Kruck, D R McLachlan.   

Abstract

Sodium cations were employed to electrostatically displace chromosomal proteins from DNA. Increasing the ambient ionic concentration resulted in a characteristic dissociation pattern of chromatin which was analyzed on polyacrylamide gels. This method of sodium chloride extraction of nuclei in vitro has been used to investigate the state of compaction of chromatin in normal and Alzheimer affected neocortical nuclei and in control nuclei treated with aluminum lactate in vitro. Our results indicate that by employing specific chelating agents such as desferrioxamine in vitro, nuclear bound aluminum is particularly resistant to removal by chelation and an increase in the affinity of linker histones H1 and H1 degree for DNA occurs both in Alzheimer's disease and in the presence of aluminum salts in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3601241

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  11 in total

1.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Early insight into the potential contribution of aluminum to neurodegeneration - A tribute to the research work of Robert D. Terry, Igor Klatzo, Henryk M. Wisniewski and Donald R.C. Mclachlan.

Authors:  J M Hill; M E Percy; W J Lukiw
Journal:  J Inorg Biochem       Date:  2019-09-12       Impact factor: 4.155

3.  27Al-NMR studies of aluminum transport across yeast cell membranes.

Authors:  K S Rao; K R Easwaran
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

4.  Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Authors:  W J Lukiw; H J LeBlanc; L A Carver; D R McLachlan; N G Bazan
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

5.  Aluminum in Neurological and Neurodegenerative Disease.

Authors:  Donald R C McLachlan; Catherine Bergeron; Peter N Alexandrov; William J Walsh; Aileen I Pogue; Maire E Percy; Theodore P A Kruck; Zhide Fang; Nathan M Sharfman; Vivian Jaber; Yuhai Zhao; Wenhong Li; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

6.  Neuronal gene expression in aluminum myelopathy.

Authors:  I M Parhad; C A Krekoski; A Mathew; P M Tran
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

Review 7.  Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?

Authors:  D R McLachlan; T P Kruck; W J Lukiw; S S Krishnan
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

8.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

9.  Aluminum and its potential contribution to Alzheimer's disease (AD).

Authors:  Surjyadipta Bhattacharjee; Yuhai Zhao; James M Hill; Maire E Percy; Walter J Lukiw
Journal:  Front Aging Neurosci       Date:  2014-04-08       Impact factor: 5.750

10.  Aluminum in neurological disease - a 36 year multicenter study.

Authors:  Walter J Lukiw; Theodore P A Kruck; Maire E Percy; Aileen I Pogue; Peter N Alexandrov; William J Walsh; Nathan M Sharfman; Vivian R Jaber; Yuhai Zhao; Wenhong Li; Catherine Bergeron; Frank Culicchia; Zhide Fang; Donald R C McLachlan
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.